Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 2
2003 3
2004 2
2005 2
2006 4
2007 5
2008 6
2009 5
2010 3
2011 6
2012 10
2013 10
2014 14
2015 11
2016 2
2017 1
2018 2
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16913187

77 results
Results by year
Filters applied: . Clear all
Page 1
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.
Cowawintaweewat S, Manoromana S, Sriplung H, Khuhaprema T, Tongtawe P, Tapchaisri P, Chaicumpa W. Cowawintaweewat S, et al. Asian Pac J Allergy Immunol. 2006 Mar;24(1):33-45. Asian Pac J Allergy Immunol. 2006. PMID: 16913187 Free article. Clinical Trial.
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort study.
Matsui Y, Uhara J, Satoi S, Kaibori M, Yamada H, Kitade H, Imamura A, Takai S, Kawaguchi Y, Kwon AH, Kamiyama Y. Matsui Y, et al. J Hepatol. 2002 Jul;37(1):78-86. doi: 10.1016/s0168-8278(02)00091-0. J Hepatol. 2002. PMID: 12076865 Clinical Trial.
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI. Hirose A, et al. Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. doi: 10.1016/j.taap.2007.03.031. Epub 2007 Apr 20. Toxicol Appl Pharmacol. 2007. PMID: 17555784
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatment.
Yeh ML, Huang CF, Huang CI, Hsieh MY, Hou NJ, Lin IH, Liang PC, Tsai YS, Hsieh MH, Lin ZY, Chen SC, Dai CY, Huang JF, Yu ML, Chuang WL. Yeh ML, et al. Kaohsiung J Med Sci. 2019 Oct;35(10):624-632. doi: 10.1002/kjm2.12105. Epub 2019 Jun 28. Kaohsiung J Med Sci. 2019. PMID: 31254328 Free article.
Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
Yanagimoto H, Satoi S, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Michiura T, Inoue K, Matsui Y, Tsuta K, Kon M. Yanagimoto H, et al. Nutr Cancer. 2016;68(2):234-40. doi: 10.1080/01635581.2016.1134597. Epub 2016 Feb 4. Nutr Cancer. 2016. PMID: 26847832 Clinical Trial.
Sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus.
Nagai H, Mukozu T, Ogino YU, Matsui D, Matsui T, Wakui N, Momiyama K, Igarashi Y, Sumino Y, Higai K. Nagai H, et al. Anticancer Res. 2015 Apr;35(4):2269-77. Anticancer Res. 2015. PMID: 25862889
Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model.
Ignacio RM, Kim CS, Kim YD, Lee HM, Qi XF, Kim SK. Ignacio RM, et al. Cytokine. 2015 Dec;76(2):131-137. doi: 10.1016/j.cyto.2015.06.002. Epub 2015 Jun 13. Cytokine. 2015. PMID: 26082022
Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma.
Lind PA, Naucler G, Holm A, Gubanski M, Svensson C. Lind PA, et al. Acta Oncol. 2007;46(2):230-3. doi: 10.1080/02841860600693473. Acta Oncol. 2007. PMID: 17453374 Clinical Trial.
Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.
Baek KK, Kim JH, Uhm JE, Park SH, Lee J, Park JO, Park YS, Kang WK, Lim HY. Baek KK, et al. Oncology. 2011;80(3-4):167-74. doi: 10.1159/000327591. Epub 2011 Jun 24. Oncology. 2011. PMID: 21701230
Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy.
Ito T, Urushima H, Sakaue M, Yukawa S, Honda H, Hirai K, Igura T, Hayashi N, Maeda K, Kitagawa T, Kondo K. Ito T, et al. Nutr Cancer. 2014;66(3):377-82. doi: 10.1080/01635581.2014.884232. Epub 2014 Mar 10. Nutr Cancer. 2014. PMID: 24611562 Clinical Trial.
77 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page